About CA125
Know the right treatment path.
CA125 is the
current gold-standard
test in the management
of ovarian cancer.
Although there is not currently a screening test available for ovarian cancer, CA125™ is the current gold-standard test in the management of this disease. Its use in monitoring treatment response and detecting recurrence for ovarian cancer has been tested for more than 20 years. The information that a CA125 test is able to provide, combined with other procedures, provides additional time for patients to receive therapy and benefit from their treatment.12
A prospective study recently published in the journal, Gynecologic Oncology, found that women with elevated levels of a substance called HE4 in their blood might be more likely to have ovarian cancer.9 This is an encouraging find in the search for a way to better predict ovarian malignancy and differentiate between malignant and benign tumors. Read more about this study.
